Strategic Initiative

Slingshot members are tracking this corporate initiative:

Celgene announces collaboration with Vividion Therapeutics to develop small molecule therapies

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Vividion Therapeutics


Additional Information

Additional Relevant Details The multi-year collaboration is focused on the identification and development of unique small molecules against targets for a range of oncology, inflammatory and neurodegenerative indications. The collaboration is intended to advance new small molecules that function through the ubiquitin proteasome system, modulating specific protein levels for therapeutic benefit. 
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Mar 05, 2018
Projected Implementation:
Q1, 2018
Relevance Tracked Until:
Q1, 2020
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Proteome-wide Ligand, Oncology